Joseph Group Capital Management Buys 2,317 Shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Joseph Group Capital Management raised its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 15.4% in the fourth quarter, HoldingsChannel reports. The fund owned 17,397 shares of the company’s stock after acquiring an additional 2,317 shares during the period. Joseph Group Capital Management’s holdings in Invesco Pharmaceuticals ETF were worth $1,437,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC increased its position in Invesco Pharmaceuticals ETF by 29.4% during the third quarter. FMR LLC now owns 1,057 shares of the company’s stock worth $92,000 after acquiring an additional 240 shares during the period. Jones Financial Companies Lllp increased its holdings in shares of Invesco Pharmaceuticals ETF by 195.7% during the fourth quarter. Jones Financial Companies Lllp now owns 2,176 shares of the company’s stock worth $180,000 after purchasing an additional 1,440 shares during the period. JPMorgan Chase & Co. raised its position in shares of Invesco Pharmaceuticals ETF by 241.7% in the third quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after buying an additional 2,862 shares in the last quarter. Grimes & Company Inc. bought a new stake in shares of Invesco Pharmaceuticals ETF in the fourth quarter valued at approximately $354,000. Finally, Commonwealth Retirement Investments LLC acquired a new stake in Invesco Pharmaceuticals ETF during the fourth quarter worth approximately $401,000.

Invesco Pharmaceuticals ETF Price Performance

Invesco Pharmaceuticals ETF stock opened at $84.23 on Friday. The stock’s fifty day moving average price is $85.66 and its two-hundred day moving average price is $85.70. The firm has a market cap of $255.22 million, a PE ratio of 21.82 and a beta of 0.56. Invesco Pharmaceuticals ETF has a one year low of $75.33 and a one year high of $89.87.

Invesco Pharmaceuticals ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 24th were paid a $0.2729 dividend. The ex-dividend date was Monday, March 24th. This is an increase from Invesco Pharmaceuticals ETF’s previous dividend of $0.21.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.